COVID-19 Vaccine Response in Patients with Hematologic Malignancy: A Systematic Review and Meta-Analysis

Introduction: Emerging data suggests that seroresponse (SR) in patients with hematologic malignancy following COVID-19 vaccination is likely lower than in patients without blood cancer. The objective of this study was to perform a systematic review and meta-analysis on SR in patients with hematologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Inna, Vijenthira, Abi, Betschel, Stephen, Hicks, Lisa K., Cheung, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
905.Outcomes Research-Lymphoid Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701771/
http://dx.doi.org/10.1182/blood-2021-149652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701771/
http://dx.doi.org/10.1182/blood-2021-149652

Ejemplares similares